Abstract

The aim of the work: The study of lipid-phospholipid indices depending on different pathology of biliary tract (BT) in patients with comorbid course of non-alcoholic fatty liver disease (NAFLD) in combination with obesity.Methods of research: There were examined 112 patients with NAFLD in combination with obesity and BT pathology: 60 patients with non-alcoholic hepatic steatosis (NAHS), 52 – with non-alcoholic steatohepatitis (NASH). Control group – 20 practically healthy persons (PHP). Depending on BT pathology patients with NAHS (n=60) and NASH (n=52) were divided into three subgroups: NAHS (1a group) or NASH (2a group) with chronic non-calculous cholecystitis (CNC); NAHS (1b group) or NASH (2b group) with chronic calculous cholecystitis (CCC); NAHS (1c group) or NASH (2c group) in patients with postcholecystectomical syndrome (PCES). The qualitative composition and quantitative content of lipids and phospholipids (PL) in the bloods serum were studied. Results: The least lipids changes were detected in patients with concomitant PCES comparing with groups of CNC and CCC. The data were proved by disperse and correlative analysis of connection between PL and BT pathology: at NAHS– рF=0,004; rs=0,306 (p<0,05); at NASH – рF=0,026; rs=0,279 (p<0,05). CNC and CCC led to the more increase of triglycerides level that PCES. According to the data of correlative analysis in groups of patients with NAHS and NASH was demonstrated that CNC and CCC led to the more essential decrease of sphingomyelin (SPM) level than PCES: at NAHS– rs=0,282 (p<0,05); at NASH –rs=0,317 (p<0,05).Conclusions. BT pathology influences the indices of spectrum of lipids and PL of the blood serum, first of all, PL, TG, SPM level at the different clinical forms of NAFLD in combination with obesity

Highlights

  • Міжгруповий аналіз вмісту СФМ у хворих з неалкогольний стеатогепатит (НАСГ) також свідчив про зниження цього показника відносно контролю у 1,3 та 1,5 рази в 2а (р

  • Виявлено кореляційний взаємозв’язок між вираженістю змін з боку показників спектру ліпідів сироватки крові у хворих з НАСГ порівняно з неалкогольний стеатоз печінки (НАСП): для ФЛ – rs=–0,344 (p

  • 3. Виявлено кореляційний взаємозв’язок між вираженістю змін з боку показників спектру ліпідів сироватки крові у хворих з неалкогольний стеатогепатит (НАСГ) порівняно з неалкогольний стеатоз печінки (НАСП): для ФЛ – rs=–0,344 (p

Read more

Summary

Introduction

Рівень ЛФТХ був вірогідно збільшеним в усіх групах НАСП по відношенню до ПЗО: в 1а та 1в групах з супутнім ХНХ та ПХЕС збільшення становило відповідно 1,3 (р

Objectives
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.